Suppliers / Pt Ferron Par Pharmaceuticals

Pt Ferron Par Pharmaceuticals

Indonesia Updated 9 July 2026

Pt Ferron Par Pharmaceuticals is a finished-dose manufacturer based in Indonesia. It appears in 40 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY) and JFDA (JO). Its GMP standing is certified by BPOM (ID), EMA and MHRA (UK). Customs aggregates show $697K of exports covering 12 molecules to 2 destinations in 2024.

0
active US DMFs
0
valid CEPs
2
registered plants
40
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Bekasi, Indonesia Not on file
BEKASI, Indonesia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 37 None
JFDA (JO) 3 None
BPOM (ID) None 44
EMA None 2
MHRA (UK) None 1

Scale

Year Revenue Exports Destinations
2024 Not reported $697K 2

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Pt Ferron Par Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts